This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy?
3/5 14:35
Abbott Laboratories (NYSE: ABT) is offering income investors a rare setup: a yield is approaching 3% while the business continues to grow. The stock isn't a screaming bargain, and rising costs matter, but its record as a Dividend King (increasing its dividends for 50+ consecutive...